Biofrontera AG American Depositary Shares
BFRA
BFRA was delisted on the 4th of March, 2022.
5 hedge funds and large institutions have $306K invested in Biofrontera AG American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
29% less funds holding
Funds holding: 7 → 5 (-2)
65% less capital invested
Capital invested by funds: $875K → $306K (-$569K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$354K |
| 2 |
Renaissance Technologies
New York
|
-$191K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$61.8K |
| 4 |
Jane Street
New York
|
-$60K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$4.45K |
BFRA Hedge Fund Activity: Q2 2021 in Review
5 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q2 2021, worth a combined $306K — down 65% from $875K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of BFRA and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 0 added.
The largest seller was Morgan Stanley, cutting an estimated $354K.
- 5 institutional investors held Biofrontera AG American Depositary Shares (BFRA) as of Q2 2021, down from 7 in Q1 2021.
- Funds reported $306K of Biofrontera AG American Depositary Shares stock for Q2 2021, down 65% quarter-over-quarter.
- 0 funds opened new Biofrontera AG American Depositary Shares positions in Q2 2021 and 2 closed out, a net change of -2 holders.
- The largest Biofrontera AG American Depositary Shares seller in Q2 2021 was Morgan Stanley, an estimated $354K sold.
Based on aggregated 13F filings for Q2 2021.